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Abstract
Background: Kikuchi-Fujimoto disease is a rare, idiopathic and generally self-limiting cause of lymphadenitis
of unknow etiology with a low recurrence rate. The typical clinical signs are cervical lymphadenopathy,
fever, and symptoms of respiratory infection, and less frequently chills, night sweats, arthralgia, rash, and
weight loss.
Case presentation: Here we describe two case reports of Kikuchi Fujimoto disease presenting in Milan
within the space of a few months. The first involved the recurrence of KFD in a young boy from Sri Lanka;
the second was a rare case of severe KFD complicated by HLH.
Conclusions: Pediatricians must consider KFD in the differential diagnosis of fever of unknown origin in
children, even in western countries. Although rare, recurrence and severe complications are possible. Where
symptoms suggest KFD, a systematic diagnostic approach is key. Since no guidelines on the management
of KFD are available, further studies should be conducted to investigate the therapeutic options and long
term outcome in children.
Keywords: Kikuchi-Fujimoto disease, Lymphadenitis, Recurrent lymphadenitis, Persistent fever, Relapsing
Kikuchi-Fujimoto disease, Hemophagocytic lymphohistiocytosis, HLH
Background
Kikuchi-Fujimoto disease (FKD), also called histiocytic
necrotizing lymphadenitis, is a rare, idiopathic and
generally self-limiting cause of lymphadenitis. Prevalence
of FKD is high among Japanese and other Asiatic
individuals, but only isolated cases are reported in Europe.
It was first described by the pathologists Kikuchi and
Fujimoto in 1972 [1], but its etiology remains unclear, al-
though the most likely theory suggests it is caused by one
or more unidentified agents, probably viruses, that trigger
a self-limiting autoimmune process in subjects with a gen-
etic predisposition to autoimmune response [2, 3]. KFD is
characterized by localized cervical lymphadenopathy,
fever, and symptoms of upper respiratory tract infection,
and less frequently chills, night sweats, arthralgia, rash,
and weight loss. Lymph nodes are usually painful and
tender; splenomegaly or hepatomegaly have sometimes
been described. Although rare, KFD may present with
neurologic involvement (both central and peripheral) [4].
Laboratory findings include high inflammatory marker
levels (C reactive protein [CRP] and erythrocyte sedimen-
tation rate [ESR]) and mild cytopenia [5, 6].
This clinical scenario is non-specific and can be mis-
taken for viral infection (such as mononucleosis), bacterial
adenitis (mainly tuberculosis or cat scratch disease), ma-
lignant lymphoma or systemic lupus erythematosus (SLE).
Several authors have also reported an association between
FKD and SLE [5]. The diagnosis of KFD is confirmed by
the histological analysis of an affected lymph node.
KFD is considered a benign disease, usually resolving
within a few months. However, recurrences and compli-
cations including hemophagocytic lymphohistiocytosis
(HLH) have been described in some patients. Here we
report two cases of KFD presenting in Milan within the
space of a few months. The first involved the recurrence
of KFD in a young boy from Sri Lanka; the second was a
rare case of severe KFD complicated by HLH.
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Case presentation 1
Timeline
2012 In Sri Lanka diagnosis of KFD
January 2017 Admission to our hospital for fever of 4 days
duration and bilateral cervical
lymphadenopathy
Ten day after the
admission
Lymph node biopsy was performed
Fifteen days after the
admission
Stop of the fever
Twenty-two days after
the admission
Discharged
Ten days after
discharged
Follow up visit
A 12-year-old boy was admitted to our hospital with
fever (38–39 °C) of 4 days’ duration and bilateral cer-
vical lymphadenopathy. Five years earlier, while living
in Sri Lanka, he had been admitted to the local hospital
for intermittent fever of 12 days’ duration, mild cough,
abdominal pain and significant bilateral cervical lymph-
adenopathy. Blood tests revealed very high LDH levels
(2360 IU/L) and cytomegalovirus (CMV) antibodies
(IgG and IgM). An abdomen ultrasound scan (US) was
normal. Given the persistent fever and LDH levels, ex-
cisional biopsy of a cervical lymph node was performed,
on the suspicion of a malignant lymphadenopathy. The
histological analysis showed a lymphoid follicular
hyperplasia with paracortical expansion and large areas
containing immunoblasts, histiocytes and apoptotic
cells, while atypical cells were absent. The clinical signs
associated with the histological features suggested the
diagnosis of KFD.
On his first examination after admission to our
Emergency Pediatric Department, the patient was febrile
and had a painful lymphadenopathy (3 cm in diameter)
in the right side of the neck. His physical development
was normal. Initial investigations revealed a mild
increase in CRP (1.79 mg/dL) and hepatic enzymes
(AST 51 IU, ALT 81 IU). Viral markers showed a past
CMV infection while markers for Epstein Barr Virus
(EBV), Toxoplasma gondii, Adenovirus and Parvovirus
were negative. Angiotensin-converting enzyme (ACE)
levels were normal. A chest X-ray was normal, while a
neck US showed the presence of two hypoechoic and
slightly inhomogeneous lymph nodes, with rich vascular-
ized hilum and no evidence of colliquative phenomena.
Some other small lymph nodes were also found in the
submandibular region. Given the association of fever,
cervical lymphadenopathies and mildly elevated inflam-
matory index, intravenous antibiotic therapy with cefo-
taxime (100 mg/kg/day) and analgesic oral therapy with
paracetamol were started.
A tuberculin intradermal reaction was negative. As the
blood tests confirmed the increase in hepatic enzymes, an
abdomen US was performed, showing severe steatosis.
Hepatitis B and C and HIV viral markers were negative;
hepatic autoantibodies and LKM were negative, ANA and
ASMA were mildly positive (ANA 1:80 homogeneous
pattern, ASMA 1:80 vascular pattern), anti ds-DNA and
the complement fraction (C3 and C4) were normal. Thy-
roid function, cholesterol (LDL and HDL) and A and B
apolipoprotein were normal. Blood and urine copper and
serum ceruloplasmin levels were normal. Urine galactose
and fructose were normal.
Due to the persistence of intermittent fever,
lymphadenopathy and the appearance of a diffuse
erythematosus and itchy rash on the trunk, arms, and legs,
an excisional lymph node biopsy was performed. The
cytometric investigation showed B lymphocytes with
non-malignant features, with just a reduced CD4 to CD8
lymphocyte ratio. The histologic exam revealed histiocytic
necrotizing lymphadenitis, confirming the diagnosis of re-
current KFD (Fig. 1, Fig. 2). The microscopic and cultural
exams were negative.
The intermittent fever lasted 15 days, then the patient’s
general condition improved, with progressive complete
normalization of blood tests. The boy was discharged
without therapy. Seven days later, at the follow-up visit, he
was still afebrile and in good general condition.
Case presentation 2
Timeline
April 2017 Admission to our hospital and start of
cefotaxime therapy
Day after admission Resolution of the fever
Six days after admission Reappearance of fever, enlargement of the
lymphadenopathies and worsening of the
blood exams
Eleven days after
admission
Cefotaxime was replaced by piperacillin/
tazobactam (150 mg/kg/day) and
vancomycin (40 mg/kg/day) with regression
of fever
Twenty days after
admission
The fever returned and progressive
enlargement of the previous
lymphadenopathies. An excisional cervical
lymph node was performed.
Twenty-eight after
admission
Diagnosis of initial HLH
A month after the
admission
Diagnosis of posterior reversible
encephalopathy syndrome (PRES)
A month and five days
after the admission
Discharged
Ten days after discharged Follow-up visit
A previously healthy 16-year-old Chinese girl came to the
Emergency Pediatric Department with progressive fever,
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cough, headache and tender right cervical lymphadenop-
athy of four days’ duration. She also complained of intense
fatigue and dizziness and had had two episodes of syncope.
She was initially treated at home with oral amoxicillin/cla-
vulanate for four days, without improvement. On physical
exam, she had a tender right retro-angulo-mandibular
lymphadenopathy of 3 cm in diameter, without hepatosple-
nomegaly, and hyperemic pharynx. An initial US revealed
the presence of multiple bilateral lymphadenopathies of dif-
ferent sizes (the largest 2.7 cm) with inflammatory charac-
teristics (hypo-anechoic and hypervascularized nodes with
perilesional hyperechoic tissues). CRP was 2.06 mg/dL
(normal value < 0.5 mg/dL). A complete blood count re-
vealed leukopenia with a white blood cell count (WBC) of
3690 cells/mm3. A broad-spectrum intravenous antibiotic
therapy was started (cefotaxime 100 mg/kg/day), with par-
tial regression of the lymphadenopathies and resolution of
the fever. After six days, she recommenced having two daily
fevers of up to 41 °C with progressive enlargement of the
lymphadenopathies, which became extremely painful. New
tender bilateral lymphadenopathies appeared in the in-
guinal and axillary areas. Blood tests revealed a worsening
leukopenia with WBC 1930 cells/mm3, neutrophils 760
cells/mm3, ESR 33 mm/h (normal value < 20 mm/h), fer-
ritin 1303 ng/dL, LDH 857 U/L. Due to persistent dry
cough, oral clarithromycin was started (15 mg/kg/day). A
thorax X ray and abdominal US were normal, while lymph
node US was unchanged. EBV, human immunodeficiency
virus (HIV), CMV and multiple other viral, bacterial and
fungal serum tests were all negative. Mantoux and Quanti-
feron Test were negative. Autoimmune lymphoproliferative
syndrome was ruled out, due to the absence of α/β
double-negative T cells.
Given her history suspicious for hematological disorders,
bone marrow aspiration was performed, which revealed a
slightly hypocellular marrow, with focal evidence of
hemophagocytosis. Flow cytometry was negative for
lymphoproliferative disorders and cytogenetic testing was
normal. Perforin gene mutations were absent. Due to the
persistence of high fever and painful lymphadenopathies,
cefotaxime was replaced by piperacillin/tazobactam
(150 mg/kg/day) and vancomycin (40 mg/kg/day). After
24 h, there was regression of the fever by lysis and
regression of the systemic lymphadenopathies, associated
with an improvement in inflammatory markers, except for
persistent neutropenia.
One week later, the fever returned and the patient
reported intense fatigue, malaise and progressive
enlargement of the previous lymphadenopathies, which
were extremely painful and swollen. An excisional
cervical lymph node biopsy was then performed, which
was diagnostic for KFD (Fig. 3): as in case 1, the biopsy
revealed wedge-shaped subcapsular necrotic foci com-
posed of fibrinoid material with karyorrhectic debris,
histiocytes with plasmacytoid features and crescentic
nuclei, and several mitotically active immunoblasts; no
granulocytic component was found. While in case 1 the
finding was focal in the lymph node (that showed an
overall preserved architecture with hyperplastic germi-
nal centers) but extensive in the tissue fragments, in this
case the lymph node was effaced by numerous necrotic
foci. Immunohistochemistry revealed in both cases a
T-cell phenotype (CD3+, CD2+, CD5+, CD7+, CD43+,
CD8+ > CD4+) for the immunoblasts, along with focal
and weak positivity for CD30, and a high proliferation
index (Ki-67 / MIB-1 = 60%); ALK-1, EMA, CD25,
CD56 and TdT were all negative. The B-cell markers
CD20 and PAX5 highlighted only a few, scattered
B-cells. Plasmacytoid histiocytes stained positively for
CD68PG-M1 and CD123. In situ hybridization for
Epstein-Barr virus was negative.
Fig. 2 Detail of Case 1, tissue fragment (hematoxilin-eosin, 20×).
Plasmacytoid histiocytes (arrows) and large immunoblastic cells in a
necrotic and karyorrhectic background, devoid of granulocytes. Inset
shows a CD3 immunohistochemical stain (20×), demonstrating that
most of the large cells have a T-cell phenotype
Fig. 1 Case 1, 3rd level laterocervical lesion, including a
lymphnode (1 cm in diameter) and several small tissue
fragments (0.3 cm the largest) Lymph node (hematoxilin-eosin,
2×). The circle indicates the only small subcapsular necrotic
focus. Inset shows a 20× magnification of the focus: note
karyorrhectic debris and several large immunoblastic cells
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This histological picture suggested a T-cell neoplasm
as the main differential diagnosis [6, 7]: however, the ab-
sence of T-cell antigen loss and of polyclonal T-cell re-
ceptor gamma chain rearrangement [8] were not
indicative of a T-cell malignancy. Additionally, the clin-
ical history, and the somewhat peculiar histological fea-
tures (presence of a histiocytic component with typical
plasmacytoid morphology in the background of fibrinoid
necrosis, and absence of a granulocytic component),
were indicative of KFD (relapsed in case 1) in the “prolif-
erative” phase [9–12].
After 4 days, the fever spontaneously disappeared.
However, inflammatory markers were still elevated, with
alteration of liver enzymes and coagulation pattern (ALT
875 U/L, AST 342 U/L, LDH 1682 U/L, CRP 3.65 mg/dL,
ferritin 9329 ng/mL, APTT 1.30, D-Dimer 2888 ng/mL,
WBC 1500 cells/mm3, neutrophils 760 cells/mm3), sug-
gestive of initial HLH. The patient was started on pulsed
methylprednisolone therapy (1 g/day for 3 days) followed
by prednisone (1.5 mg/kg/day) in combination with cyclo-
sporine (4 mg/kg/day). A rapid improvement in her
lymphadenopathies, fever and constitutional symptoms
was seen soon after immunosuppressive therapy was
started. A progressive normalization of blood analysis was
also observed, with improvement of the leukopenia.
Although her symptoms improved with high doses of
prednisone, the clinical course was complicated by the
development of glucocorticoid-induced diabetes and
hypertension. After four days of steroid treatment, the
patient had a sudden rise in blood pressure (162/
108 mmHg) associated with headache and malaise. Some
hours later, she presented two generalized tonic-clonic
seizures with cyanosis, requiring the administration of
oxygen and intravenous diazepam. We performed an
urgent computerized tomography (CT) brain scan,
which was normal. Given the combination of generalized
seizures, high blood pressure and immunosuppressive
therapy, magnetic resonance imaging (MRI) of the brain
was then performed, which showed pathological alter-
ations suggestive of posterior reversible encephalopathy
syndrome (PRES). An electroencephalogram (EEG)
proved abnormal and antiepileptic therapy with Leveti-
racetam (750 mg/day) was started, achieving good con-
trol of the crisis. The hypertension was treated with
amlodipine (10 mg/day). Follow-up brain MRI and EEG
after 10 days showed a complete normalization of the
previously described neurological alterations, thus con-
firming the diagnosis of PRES. Levetiracetam was then
stopped and the anti-hypertensive therapy was gradually
reduced. The patient continued high dose corticoste-
roids with a slow taper over several months in combin-
ation with cyclosporine and was discharged in good
clinical condition.
Discussion
Kikuchi-Fujimoto disease is a rare benign disease
associated with histiocytic necrotizing lymphadenitis. It
is endemic in Asia, especially among young women, but
only isolated cases are reported in Europe and therefore
its diagnosis may be difficult. FKD is characterized by
lymphadenopathy with tenderness, night sweats and
fever, less common manifestations include generalized
lymphadenopathy, weight loss, splenomegaly, cutaneous
rash, arthralgia, weight loss, nausea, vomiting and
neurologic involvement. Although the lymphadenopathy
usually affects the cervical lymph nodes, the axillary
lymph nodes and other regions can also be affected. The
affected lymph nodes are solid, movable, and painful but
not suppurative; while the main affected node is usually
solitary, multiple lymph nodes on both sides have been
described [5, 6]. KFD is typically reported to have a
self-limiting course, resolving within several months and
with a recurrence rate of just 3 to 4% [13]. In our first
patient, a young boy of Asian origin, KFD recurred five
years after its first manifestation.
KFD remains an enigmatic disease, not only for its
rarity and non-specific manifestations, but also because
its etiology and pathogenesis remain unclear and there
are no clear diagnostic criteria. Even though it is a be-
nign condition, correct diagnosis is fundamental to rule
out other causes of lymphadenopathy. Cervical lymph-
adenopathy is in fact common in the pediatric popula-
tion, with about 38 to 45% of otherwise healthy children
having palpable lymphadenopathy. For this reason, KFD
can be mistaken for other common or more serious con-
ditions, such as lymphoma or systemic lupus erythema-
tosus - another hard-to-diagnose disease in children due
to its widely varying symptoms [14].
Fig. 3 Case 2, a submandibular lymphnode (1,5 in diameter,
hematoxilin-eosin, 2×). The circle indicates plurifocal subcapsular
necrotic foci. Inset shows a 20× magnification of the largest focus: it
was composed of fibrinoid material, karyorrhectic debris and several
large immunoblastic cells
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The non-specific presentation requires numerous inves-
tigations. Excisional lymph node biopsy is the only reliable
means of establishing a diagnosis, but a systematic ap-
proach is fundamental to exclude other causes of persist-
ent fever and lymphadenitis and identify when biopsy is
necessary. The starting diagnostic point is a collection of a
careful medical history and a thorough physical examin-
ation. It is important to consider all symptoms (such as
fever, anorexia, weight loss, night sweats, fatigue), their
onset and duration, any insect bites, any changes in mass
size, other recent illnesses or travel, exposure to animals,
treatments (such as antibiotics) and response to them,
vaccinations, family history, and the patient’s origins. As-
sociated systemic symptoms, such as weight loss, night
sweats, unexplained fever, or fatigue, suggest the need for
further workup for possible malignancy or chronic inflam-
matory conditions. A careful examination should then be
conducted to identify the number of masses, their loca-
tion, size, mobility, tenderness, and characteristics of the
masses on palpation and of the overlying skin. A complete
physical examination of all body systems is necessary: in-
fection is the most common cause of pediatric cervical
lymphadenopathy and a benign reactive lymphadenopathy
with infectious origin may be suggested by an associated
illness (viral or bacterial) such as an upper respiratory in-
fection, pharyngitis, tonsillitis, or otitis media [15].
While these data could orient towards a diagnosis, they
are not unequivocal. The signs and symptoms of KFD are
often enigmatic, especially in the early stages, and only their
persistence can lead to diagnosis. For these reasons, some
investigations need to be performed. Initial tests comprise
complete blood cell count with WBC differential,
erythrocyte sedimentation rate, liver enzymes and lactate
dehydrogenase (significantly associated with malignancy),
and inflammatory markers. Blood markers for virus
infections that could cause lymphadenitis (CMV, HBV,
Herpes virus, HIV, Adenovirus) and bacterial infections
(Toxoplasma gondii, Bartonella henselae, Borrelia
burgorferi) are also important [16]. Tuberculin skin test and
Interferon-gamma release assay (IGRA), a pharyngeal swab
and nasopharyngeal aspirate should also be performed.
A chest X-ray and neck US should be performed as a
first step. Abdomen US could be useful to exclude the
involvement of abdominal lymph nodes. In our patients,
neck US features indicated benign or reactive lymph
nodes. Fatty liver was found in case 1; this has never be-
fore been described in the manifestation of KFD. A co-
hort study should be conducted to evaluate hepatic US
of these patients, although this finding was probably in-
dependent of the underlying disease.
If the initial investigation is inconclusive, or if
indicated, additional investigations could include testing
for Listeria monocytogenes and Francisella tularensis and
ACE assay to exclude sarcoidosis. If, such as in our
patients, symptoms persist and no definitive diagnosis
has been arrived at, excisional lymph node biopsy
should be performed [17].
In our first patient, biopsy was performed at an
early stage because his history (a first occurrence of
KFD five years before) and clinical course were very
similar to the previous episode. However, other
possible causes of lymphadenitis must be ruled out:
since a low KFD recurrence rate is described in the
literature, more frequent causes of lymphadenopathy
should also be considered.
Yoo IH et al. found that a past history of other
systemic illnesses and a higher Absolute Lymphocyte
Count (ALC) despite a reduced WBC count were
significantly associated with recurrent KFD, but there
are insufficient data to predict recurrence [18]. Some
data suggest that removal of the affected lymph node is
not only diagnostic but also potentially therapeutic: after
excisional lymph node biopsy some patients improve
quickly [19], as did case 1 reported herein.
KFD has a wide clinical spectrum and is generally
self-limiting. However, some patients suffer from prolonged
systemic symptoms during the course of the disease, some-
times with severe complications. These include, especially
in western countries, a few cases of secondary HLH, also
known as hemophagocytic syndrome (HS) [13, 19–23]. HS
is a histiocytic reactive process found in cases of strong im-
munologic activation such as severe infection, malignancy,
autoimmune diseases, and metabolic diseases. It is charac-
terized by histiocytic proliferation, hemophagocytosis, fever,
hepatosplenomegaly, generalized lymphadenopathy,
hypertriglyceridemia, and hypofibrinogenemia. KFD seems
to be a hyperimmune reaction of immune cells to unidenti-
fied agents; too much stress could then lead to HLH [24–
26]. The prognosis and therapeutic strategy for KFD in as-
sociation with HS remains unclear. As Kim et al. conclude,
childhood KFD is more frequently associated with HS and
seems to have a less aggressive course and better prognosis
than in adults [27].
No clear therapeutic guidelines are available on how to
shorten the clinical course of KFD. Little information is
available about the use of hydroxychloroquine or
glucocorticoids [28, 29]. While we decided not to treat our
first patient, who returned to good health after three weeks
of fever, our second patient required prompt treatment
because KFD associated with HLH has a potentially fatal
outcome [27, 30]. It should be borne in mind that during
the prolonged course of KFD, children suffer from
impaired school performance, numerous medical visits and
hospital admissions, and/or acute deterioration of health:
further studies should be conducted to clarify possible
therapeutic choices. Unfortunately, no clinical features that
significantly affect the duration of KFD have been clearly
identified, although some authors hypothesized that
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detection of atypical lymphocytes in peripheral blood may
be a predictor for its duration [31, 32].
Conclusion
Pediatricians must consider KFD in the differential
diagnosis of fever of unknown origin in children, even in
western countries: prelevalence of KFD is high among
Asiatic individuals but until now only very rare cases are
reported in Europe, however the immigration from Asian
countries is likely to cause an increase of KFD cases.
Although rare, recurrence and severe complications are
possible. Where symptoms suggest KFD, a systematic
diagnostic approach is key. Since no guidelines on the
management of KFD are available, further studies should
be conducted to investigate the therapeutic options and
long term outcome in children.
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